|1.||Illueca, Marta: 21 articles (07/2015 - 03/2006)|
|2.||Tolia, Vasundhara: 14 articles (07/2015 - 11/2007)|
|3.||Armstrong, D: 14 articles (04/2013 - 02/2000)|
|4.||Stolte, M: 14 articles (07/2006 - 01/2000)|
|5.||Lundborg, Per: 13 articles (07/2015 - 03/2006)|
|6.||Traxler, Barry: 13 articles (07/2015 - 08/2004)|
|7.||Lind, Tore: 12 articles (01/2015 - 10/2004)|
|8.||Lanas, Angel: 12 articles (10/2014 - 05/2002)|
|9.||Sung, Joseph J Y: 12 articles (07/2014 - 12/2002)|
|10.||Talley, N J: 12 articles (11/2013 - 10/2000)|
|1.||Gastroesophageal Reflux (GERD)
12/01/1995 - "In addition, studies also indicate that omeprazole is the most effective agent for the treatment of patients with GERD refractory to other treatments. "
01/01/1989 - "Several studies have clearly demonstrated that omeprazole is highly efficacious in the management of patients with gastro-oesophageal reflux disease. "
05/18/2011 - "This multicenter clinical trial demonstrated that with contemporary antireflux therapy for GERD, either by drug-induced acid suppression with esomeprazole or by LARS, most patients achieve and remain in remission at 5 years. "
07/01/2015 - "GERD symptom scores were significantly improved from baseline to the final week of the study in all of the treatment groups (P < 0.01) CONCLUSIONS:: In children ages 1 to 11 years with endoscopically proven GERD, esomeprazole (at daily doses of 5, 10, or 20 mg) was generally well tolerated. "
07/01/2015 - "GERD symptom scores were significantly improved from baseline to the final week of the study in all of the treatment groups (P < 0.01) CONCLUSIONS: In children ages 1 to 11 years with endoscopically proven GERD, esomeprazole (at daily doses of 5, 10, or 20 mg) was generally well tolerated. "
01/01/1989 - "In conclusion, omeprazole 20 mg each morning was found to be safe and highly effective for treatment of gastric and prepyloric ulcer in Korean patients, producing a 98% healing rate. "
01/01/1989 - "The healing efficacy of omeprazole was assessed in 57 Korean patients with endoscopically-proven gastric (GU) and/or prepyloric (PPU) ulcers of at least 5 mm diameter. "
04/01/1999 - "Horses treated with omeprazole had significantly (P < 0.01) more improvement in ulcer scores at the end of the study compared with controls. "
11/01/2008 - "Both the extracts produced significant reduction in ulcer index (P < 0.05) in all the models and the results were comparable with that of omeprazole-treated group. "
06/01/2005 - "DG showed significant protection against CRU (68.37%), AL (88.87%), ASP (38.2%), PL (40.63%) and HST (63.15%) induced ulcer models, whereas standard drug omeprazole (OMZ) showed protection index of 83.86, 56.35, 70.31 and 84.21%, respectively in CRU, ASP, PL and HST models. "
|3.||Duodenal Ulcer (Curling's Ulcer)
11/01/1992 - "It is concluded that omeprazole, even in the presence of adverse prognostic influences, results in significantly better healing of duodenal ulcer and relief from symptoms than H2-RA."
01/01/1994 - "As omeprazole is more effective than the H2-receptor antagonists in the acute treatment of duodenal ulcer, healing virtually all patients within 4 weeks (4), it may also be more effective in the maintenance treatment of duodenal ulcer disease. "
01/01/1989 - "Open studies using maintenance treatment with low-dose omeprazole suggest that such therapy is effective in keeping refractory duodenal ulcer healed."
03/01/1996 - "Omeprazole is less effective in healthy subjects than in patients with duodenal ulcers. "
07/01/1991 - "Omeprazole is effective and safe in the treatment of gastric and duodenal ulcers."
|4.||Peptic Ulcer (Peptic Ulcers)
08/01/1999 - "Omeprazole triple therapy is highly effective in patients with active or healed peptic ulcer disease, and is well tolerated."
06/01/1990 - "It is concluded that omeprazole is highly effective in healing refractory peptic ulcers."
02/01/1987 - "It is therefore concluded that omeprazole is highly effective in healing refractory peptic ulcers and that omeprazole maintenance therapy may be useful for prevention of relapse. "
05/01/1998 - "Both standard and high doses of omeprazole are equally safe and effective regimens for the treatment of NSAID-induced gastroduodenal ulcers when anti-inflammatory treatment is not discontinued."
04/01/2012 - "Prophylaxis with omeprazole is effective for the prevention of gastroduodenal ulcers, maintenance of remission and alleviation of dyspeptic symptoms in NSAID recipients. "
06/26/2000 - "Patients were assessed at weeks 2 and 4. The efficacy of omeprazole for the treatment of heartburn was determined mainly through the following diary card data: daily resolution of heartburn and complete resolution of heartburn every day during 1 week of treatment. "
01/01/1993 - "In two studies against omeprazole, no significant difference was found in healing rates, while a Scandinavian study demonstrated more prompt relief from heartburn. "
07/01/2014 - "Within the first 4 days, the proportion of subjects with heartburn-free days was significantly greater with esomeprazole 20 mg versus placebo. "
01/01/2012 - "The mean number of heartburn-free days by D7 was significantly greater in the omeprazole group: 3.7 ± 2.3 days vs. 3.1 ± 2.1 (p = 0.02). "
02/01/1993 - "Omeprazole also provided significantly greater relief from daytime heartburn, nighttime heartburn, and acid regurgitation, and was associated with decreased concomitant antacid use. "
|8.||Proton Pumps (Proton Pump)